Showing 8331-8340 of 10256 results for "".
- Dermatomyositis Breakthrough? Drug reduces disease burden in patients with skin-predominant DMhttps://practicaldermatology.com/news/dermatomyositis-breakthrough-drug-reduces-disease-burden-in-patients-with-skin-predominant-dm/2457990/A new treatment for dermatomyositis (DM) may reduce the severity of the disease in patients whose DM was resistant to other therapies. As part of a randomized, double-blind study conducted at the Perelman School of Medicine at the University of Pennsyl
- Chris Greta Appointed Chief Creative Officer at eRelevancehttps://practicaldermatology.com/news/chris-greta-appointed-chief-creative-officer-at-erelevance/2457996/Chris Greta has been appointed as the first chief creative officer for
- FDA Clears Xstrahl Photoelectric Therapy Systemhttps://practicaldermatology.com/news/fda-clears-xstrahl-photoelectric-therapy-system/2458005/Xstrahl has received FDA 510K clearance for the marketing of its latest skin cancer therapy device. The Photoelectric Therapy System is a compact and ergonomic superficial X-Ray therapy system operating in the 10kV to 80kV range intended for superficial radiotherapy and surface electronic brachyt
- PruGen Pharmaceuticals Takes Action to Aid Hurricane Relief Effortshttps://practicaldermatology.com/news/prugen-pharmaceuticals-takes-action-to-aid-hurricane-relief-efforts/2458007/In the wake of several devastating and destructive hurricanes in the continental US and Puerto Rico, PruGen Pharmaceuticals is helping to those in need. The PruGen Foundation, a nonprofit organization founded by PruGen Pharmaceuticals and focused on philanthropic
- Eau Thermale Avène Expands its #AveneHope Programhttps://practicaldermatology.com/news/eau-thermale-avne-expands-its-avenehope-program/2458015/In recognition of Eczema Awareness Month and National Bullying Prevention Awareness Month this October, Eau Thermale Avène is expanding its #AveneHope program to
- Silk'n Introduces Titan by Silk'n for Home Usehttps://practicaldermatology.com/news/silkn-introduces-titan-by-silkn-for-home-use/2458025/Home-use devices represent a hot growth category, and Silk'n is now introducing Titan by Silk'n for at-home skin tightening and lifting. Titan combines infrared energy to increase blood circulation and improve skin tone and texture, LED ligh
- SmartGraft Taps Industry Vet as New EVPhttps://practicaldermatology.com/news/smartgraft-taps-new-evp/2458031/Joseph R. Brown is the new Executive Vice President for SmartGraft®, a minimally invasive hair restoration
- Warning: Sindoor Used in Hindu Ceremonies May Contain Unsafe Lead Levelshttps://practicaldermatology.com/news/warning-sindoor-used-in-hindu-ceremonies-may-contain-unsafe-lead-levels/2458037/Sindoor – a cosmetic powder sold in the United States and used during Hindu religious and cultural ceremonies – may contain unsafe levels of lead, Rutgers University researchers warn. Researchers from the School of Public Health reported that 83 percent of the samples collecte
- Allergan Adds Coolsculpting, Other Bells and Whistles to Brilliant Distinctions® Patient Loyalty Programhttps://practicaldermatology.com/news/allergan-adds-coolsculpting-other-bells-and-whistles-to-brilliant-distinctions-patient-loyalty-program/2458056/Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and drive increased member engagement. In addition
- RXI Completes Enrollment of Phase 2 Study of Samcyprone for Cutaneous Wartshttps://practicaldermatology.com/news/rxi-completes-enrollment-of-phase-2-study-of-samcyprone-for-cutaneous-warts/2458067/RXi Pharmaceuticals Corporation completed enrollment in its Phase 2 clinical trial, RXI-SCP-1502, with Samcyprone™for the clearance of cutaneous warts. Samcyprone™ is a proprietary topical formulation of the small molecule diphenylcyclopr